Kedrion Launches FDA-Approved Gammaked in the U.S. Market
The U.S. Food and Drug Administration has approved Kedrion Biopharma’s Gammaked for the U.S.market.
FDA Approves Menactra for Infants from 9 Months
Menactra, a vaccine for the prevention of invasive meningococcal disease for children ages 9 months and older, has been approved by the U.S. Food and Drug Administration.
FDA Approves Shingles Vaccine for Ages 50-59
Zostavax, the vaccine manufactured by Merck & Co. to prevent shingles, has been approved by the U.S. Food and Drug Administration for adults ages 50 to 59 years old.
FDA Approves 60-Second HIV Test
The U.S. Food and Drug Administration has approved a single-use rapid test that detects antibodies to HIV-1 in as little as 60 seconds.
FDA Extends Shelf Life of Hizentra to 30 Months
The U.S.Food and Drug Administration has approved a supplemental Biologics License Application to extend the shelf life of Hizentra.
FDA Approves First Drug to Treat Lupus
The U.S. Food and Drug Administration (FDA) has approved Benlysta (belimumab) to treat patients with active autoantibody positive lupus (systemic lupus erythematosus) who are receiving standard therapy, including corticosteroids, antimalarials, immunosuppressives and non steroidal anti-inflammatory drugs.
FDA OKs Prolastin-C for AAT Deficiency
Prolastin-C has been approved by the Food and Drug Administration for the treatment of alpha1-antitrypsin (AAT)deficiency.